Gill G, Mbanya JC, Ramaiya K, Tesfaye S: A sub-Saharan African perspective of diabetes. Diabetologia. 2009, 52: 8-16. 10.1007/s00125-008-1167-9.
Article
CAS
PubMed
Google Scholar
Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87: 4-14. 10.1016/j.diabres.2009.10.007.
Article
CAS
PubMed
Google Scholar
Pascolini D, Mariotti SP: Global estimates of visual impairment: 2010. BJO. 2012, 96: 614-618. 10.1136/bjophthalmol-2011-300539.
Article
Google Scholar
Marshall G, Garg SK, Jackson WE, Holmes DL, Chase HP: Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology. 1993, 100: 1133-1139.
Article
CAS
PubMed
Google Scholar
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986.
Article
Google Scholar
Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL: Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998, 39: 233-252.
CAS
PubMed
Google Scholar
Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR: UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001, 44: 156-163. 10.1007/s001250051594.
Article
CAS
PubMed
Google Scholar
UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998, 317: 703-713. 10.1136/bmj.317.7160.703.
Article
PubMed Central
Google Scholar
Agardh CD, Agardh E, Torffvit O: The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract. 1997, 35: 113-121. 10.1016/S0168-8227(97)01386-7.
Article
CAS
PubMed
Google Scholar
Gallego PH, Craig ME, Hing S, Donaghue KC: Role of blood pressure in development of early retinopathy in adolescents with type 1 diabetes: prospective cohort study. BMJ. 2008, 337: a918-10.1136/bmj.a918.
Article
PubMed
PubMed Central
Google Scholar
Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH: Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998, 351: 28-31. 10.1016/S0140-6736(97)06209-0.
Article
CAS
PubMed
Google Scholar
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M, FIELD study investigators: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005, 366: 1849-1861.
Article
CAS
PubMed
Google Scholar
The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981, 88: 583-600.
Article
Google Scholar
Early Treatment Diabetic Retinopathy Study research group: Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthal. 1985, 103: 1796-1806.
Article
Google Scholar
Burgess PI, Maccormick IJ, Harding SP, Bastawrous A, Beare NA, Garner P: Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. Diabet Med. 2013, 30: 399-412. 10.1111/j.1464-5491.2012.03756.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cockburn N, Steven D, Lecuona K, Joubert F, Rogers G, Cook C, Polack S: Prevalence, causes and socio-economic determinants of vision loss in Cape Town, South Africa. PLoS One. 2012, 7: e30718-10.1371/journal.pone.0030718.
Article
CAS
PubMed
PubMed Central
Google Scholar
World Health Organization: Coding Instructions for the WHO/PBL Eye Examination Record (version III). PBL/88.1. 1988, Geneva: WHO
Google Scholar
Younis N, Broadbent DM, Harding SP, Vora JP: Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med. 2002, 19: 1014-1021.
Article
CAS
PubMed
Google Scholar
Younis N, Broadbent D, Vora J, Harding S: Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003, 361: 195-200. 10.1016/S0140-6736(03)12267-2.
Article
PubMed
Google Scholar
Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984, 102: 527-532. 10.1001/archopht.1984.01040030405011.
Article
CAS
PubMed
Google Scholar
Tapp RJ: Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract. 2006, 73: 298-303. 10.1016/j.diabres.2006.02.009.
Article
PubMed
Google Scholar
Gill GV: Long-term (20 years) outcome and mortality of Type 1 diabetic patients in Soweto, South Africa. Diabet Med. 2005, 22: 1642-6. 10.1111/j.1464-5491.2005.01712.x.
Article
CAS
PubMed
Google Scholar
Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, Unwin N: Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Publ Health. 2007, 7: 234-10.1186/1471-2458-7-234.
Article
Google Scholar
Young FCJ, Johnstone LK, Unwin NC: A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus. HIV and metabolic syndrome. Global Health. 2009, 5: 9-10.1186/1744-8603-5-9.
Article
PubMed
PubMed Central
Google Scholar
Mash B, Powell D, du Plessis F, van Vuuren U, Michalowska M, Levitt N: Screening for diabetic retinopathy in primary care with a mobile fundal camera–evaluation of a South African pilot project. S Afr Med J. 2007, 97: 1284-8.
PubMed
Google Scholar
Joannou J, Kalk WJ, Mahomed I, Ntsepo S, Berzin M, Joffe BI, Raal FJ, Sachs E, van der Merwe MT, Wing JR: Screening for diabetic retinopathy in South Africa with 60 degrees retinal colour photography. J Intern Med. 1996, 239: 43-47. 10.1046/j.1365-2796.1996.413755000.x.
Article
CAS
PubMed
Google Scholar
Read O, Cook C: Retinopathy in diabetic patients evaluated at a primary care clinic in Cape Town. S Afr Med J. 2007, 97: 941-942. 4
PubMed
Google Scholar
Carmichael TR, Carp GI, Welsh ND, Kalk WJ: Effective and accurate screening for diabetic retinopathy using a 60 degree mydriatic fundus camera. S Afr Med J. 2005, 95: 57-61.
CAS
PubMed
Google Scholar
Mumba M, Hall A, Lewallen S: Compliance with eye screening examinations among diabetic patients at a Tanzanian referral hospital. Ophthalmic Epidemiol. 2007, 14: 306-310. 10.1080/09286580701272079.
Article
PubMed
Google Scholar
Kirigia JM, Sambo HB, Sambo LG, Barry SP: Economic burden of diabetes mellitus in the WHO African region. BMC Int Health Hum Rights. 2009, 9: 6-10.1186/1472-698X-9-6.
Article
PubMed
PubMed Central
Google Scholar
Bradshaw D, Norman R, Pieterse D, Levitt NS, South African Comparative Risk Assessment Collaborating Group: Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J. 2007, 97: 700-706.
PubMed
Google Scholar
Fong DS, Aiello L, Gardner TW, American Diabetes Association: Retinopathy in diabetes. Diabetes Care. 2004, 27: S84-S87. 10.2337/diacare.27.2007.S84.
Article
PubMed
Google Scholar
Zhang PZX, Brown JB, Vistisen D, Sicree RA, Shaw J, Nichols GA: Economic Impact of Diabetes. Diabetes Atlas, IDF. 2009, International Diabetes Federation: Brussels, 4
Google Scholar
WHO Country cooperation strategy Malawi. [http://www.who.int/countryfocus/cooperation_strategy/ccsbrief_mwi_en.pdf]
Report on the United Nations high level meeting on non-communicable disease prevention and control. [http://www.who.int/nmh/events/un_ncd_summit2011/en/]
Resnikoff S, Felch W, Gauthier TM, Spivey B: The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners. Br J Ophthalmol. 2012, 96: 783-787. 10.1136/bjophthalmol-2011-301378.
Article
PubMed
Google Scholar
Bastawrous A, Hennig BD: The global inverse care law: a distorted map of blindness. Br J Ophthalmol. 2012, 96: 1357-1358.
Article
PubMed
PubMed Central
Google Scholar
UN data: Country profile Malawi 2009. [http://data.un.org/CountryProfile.aspx?crName=MALAWI]
WHO World Health Report. 2002, Geneva: WHO, [http://www.who.int/whr/2002/], : Reducing risks, promoting healthy life
Whiting DR, Hayes L, Unwin NC: Diabetes in Africa. Challenges to health care for diabetes in Africa. J Cardiovasc Risk. 2003, 10: 103-110. 10.1097/00043798-200304000-00005.
Article
PubMed
Google Scholar
Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D: The burden of non-communicable diseases in South Africa. Lancet. 2009, 374: 934-47. 10.1016/S0140-6736(09)61087-4.
Article
PubMed
Google Scholar
Floyd S, Molesworth A, Dube A, et al: Population-level reduction in adult mortality after extension of freeanti-retroviral therapy provision into rural areas in northern Malawi. PLoS One. 2010, 5: e13499-10.1371/journal.pone.0013499.
Article
PubMed
PubMed Central
Google Scholar
Nguyen C, Cheng-Lai A: The polypill: a potential global solution to cardiovascular disease. Cardiol Rev. 2013, 21: 49-54. 10.1097/CRD.0b013e3182755429.
Article
PubMed
Google Scholar
Network DRCR: Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010, 117: 1064-1077. 10.1016/j.ophtha.2010.02.031.
Article
Google Scholar
Virgili G, Parravano M, Menchini F, Brunetti M: Cochrane Intervention review: Anti-angiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. The Cochrane library. [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007419.pub3/abstract]
Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG: A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol. 2012, 130: 972-979. 10.1001/archophthalmol.2012.393.
Article
CAS
PubMed
Google Scholar
Harding SP, Broadbent DM, Neoh C, White MC, Vora J: Sensitivity and specificity ofphotography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study. BMJ. 1995, 311: 1131-1135. 10.1136/bmj.311.7013.1131.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones S, Edwards RT: Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med. 2010, 27: 249-256.
Article
CAS
PubMed
Google Scholar
NHS Diabetic eye screening programme. [http://diabeticeye.screening.nhs.uk]
Younis N, Broadbent DM, Vora JP, Harding SP: Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003, 361: 195-200. 10.1016/S0140-6736(03)12267-2.
Article
PubMed
Google Scholar
Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L: Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycaemic control. Acta Ophthalmol Scand. 1996, 74: 523-527.
Article
CAS
PubMed
Google Scholar
Kristinsson JK, Stefonsson E, Janasson F, Goslason I, Bjornsson S: Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol. 1994, 72: 341-346.
Article
CAS
Google Scholar
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R: Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010, 304: 649-656. 10.1001/jama.2010.1111.
Article
CAS
PubMed
PubMed Central
Google Scholar
The ACCORD Study Group and ACCORD Eye Study Group: Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010, 363: 233-244.
Article
Google Scholar
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321: 405-412. 10.1136/bmj.321.7258.405.
Article
CAS
PubMed
PubMed Central
Google Scholar
James M, Turner D, Broadbent DM, Vora J, Harding SP: Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000, 320: 1627-1631. 10.1136/bmj.320.7250.1627.
Article
CAS
PubMed
PubMed Central
Google Scholar
Murthy KR, Murthy PR, Kapur A, Owens DR: Mobile diabetes eye care: experience in developing countries. Diabetes Res Clin Pract. 2012, 97: 343-349. 10.1016/j.diabres.2012.04.025.
Article
PubMed
Google Scholar
Rachapelle S, Legood R, Alavi Y, Lindfield R, Sharma T, Kuper H, Polack S: The cost-utility of telemedicine to screen for diabetic retinopathy in India. Ophthalmology. 2013, 120: 566-573. 10.1016/j.ophtha.2012.09.002.
Article
PubMed
Google Scholar